Speak directly to the analyst to clarify any post sales queries you may have.
The RFID Blood Monitoring System Market is advancing as healthcare providers demand greater visibility, compliance, and safety in blood management. Organizations are integrating RFID-enabled tracking to automate workflows, improve inventory accuracy, and ensure the integrity of blood products throughout the supply chain.
Market Snapshot: RFID Blood Monitoring System Market Size and Growth
The RFID Blood Monitoring System Market grew from USD 179.33 million in 2024 to USD 204.24 million in 2025. It is expected to continue growing at a CAGR of 14.62%, reaching USD 534.28 million by 2032.
Scope & Segmentation
This report provides comprehensive analysis across major segments, enabling leaders to assess the market landscape confidently and identify actionable opportunities.
- Component Type: Hardware (Antennas, Middleware, Readers, Tags), Services (Consulting Services, Implementation Services, Maintenance and Support, Managed Services), Software
- Technology: Active RFID Technology, Passive RFID Technology
- Application: Blood Sample Tracking, Blood Storage Monitoring, Blood Transfusion Monitoring, Inventory Management, Patient Identification
- End-User: Blood Banks (Private, Public), Diagnostic Laboratories, Healthcare Providers (Ambulatory Surgical Centers, Clinics, Hospitals)
- Regions: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
- Companies Analyzed: Alien Technology, LLC; Biolog-id; Cardinal Health, Inc.; GAO RFID Inc.; Mobile Aspects Inc.; SATO Vicinity Pty. Ltd.; Terso Solutions, Inc.; Bagmo Pvt Ltd; Zebra Technologies; Kent Scientific Corporation
Key Takeaways for Senior Decision-Makers
- Adoption of RFID blood monitoring systems significantly improves patient safety and operational efficiency by automating real-time tracking and streamlining chain of custody.
- Regulatory agencies are driving increased demand for advanced monitoring solutions by enforcing stricter traceability and compliance requirements in blood management workflows.
- Technological advancements, including IoT connectivity, machine learning, sensor miniaturization, and integration with cloud-based analytics, are transforming how blood products are monitored and managed in diverse healthcare environments.
- Decision-makers are prioritizing interoperability and data integration with EHRs and laboratory information systems to strengthen audit trails and reporting.
- Strategic partnerships across technology providers, healthcare institutions, and regulatory bodies support standardization, faster adoption, and enhanced system reliability.
Tariff Impact on RFID Blood Monitoring System Supply Chains
New tariffs on imported RFID components in 2025 have affected cost structures for vendors and healthcare organizations. Hardware such as antennas, readers, tags, and middleware now face higher duties, impacting system deployment budgets. Service contracts and software packages reliant on bundled hardware may also see pricing adjustments. As a result, procurement leaders are reassessing project timelines and budgets to address rising expenses. To mitigate these challenges, some organizations are adopting localization strategies, establishing domestic manufacturing partnerships, and negotiating risk-sharing frameworks with suppliers.
RFID Blood Monitoring System Market: Methodology & Data Sources
Analysis is grounded in direct interviews with clinical professionals, laboratory supervisors, and supply chain managers. A robust secondary review of industry publications, regulatory guidelines, and technical literature informs benchmarking. Aggregated survey data, statistical correlation, and expert validation ensure accurate representation of current trends and market perspectives.
Why This Report Matters
- Enables senior leaders to identify areas for operational improvement, efficiency gains, and error reduction in blood monitoring processes.
- Supports the evaluation of best-fit technology solutions by offering segmentation perspectives and highlighting market innovations.
Access actionable intelligence to inform investments, implementation planning, and partnership development in a rapidly evolving sector.
Conclusion
RFID blood monitoring is shaping new standards of precision, safety, and compliance in healthcare. Leaders equipped with this analysis can confidently chart investment strategies and implementation plans tailored to future-proof their blood management operations.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Samples
LOADING...
Companies Mentioned
The key companies profiled in this RFID Blood Monitoring System market report include:- Alien Technology, LLC
- Biolog-id
- Cardinal Health, Inc.
- GAO RFID Inc.
- Mobile Aspects Inc.
- SATO Vicinity Pty. Ltd.
- Terso Solutions, Inc.
- Bagmo Pvt Ltd
- Zebra Technologies
- Kent Scientific Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 187 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 204.24 Million |
| Forecasted Market Value ( USD | $ 534.28 Million |
| Compound Annual Growth Rate | 14.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
